Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Saskatchewan to fund treatment with AUBAGIO® for Relapsing Remitting Multiple Sclerosis
Yahoo/CNW Group
Saturday, November 1, 2014 - 12:52pm
tags:
Aubagio, multiple sclerosis, MS, Sanofi
Investors Could Triple Their Investments in AbbVie
Yahoo/Guru Focus
Saturday, November 1, 2014 - 12:48pm
tags:
AbbVie
Alkermes Incurs Wider Q3 Loss but Revenues Grow Y/Y
Yahoo/Zacks
Saturday, November 1, 2014 - 12:46pm
tags:
Alkermes, earnings
Fundamentals, Technicals Still Intact At Gilead Sciences
Investor's.com
Saturday, November 1, 2014 - 12:45pm
tags:
Gilead Sciences
Gilead Sciences: Harvoni Still Selling Like Hotcakes
Barron's
Friday, October 31, 2014 - 2:14pm
tags:
Gilead Sciences, hepatitis C, Harvoni
A ‘Strange Back and Forth’ Between Sarepta and the FDA
WSJ Pharmalot
Friday, October 31, 2014 - 2:13pm
tags:
Sarepta Therapeutics, FDA, eteplirsen, Duchenne Muscular Dystrophy
AbbVie CEO: Unlikely to Pursue Another $50 Billion Deal
WSJ Online
Friday, October 31, 2014 - 2:02pm
tags:
AbbVie, M&A, Rick Gonzalez
FDA Advisory Panel Gives Tepid Support To New Daiichi Sankyo Drug
Forbes
Friday, October 31, 2014 - 2:01pm
tags:
FDA, Daiichi Sankyo, advisory panels, bloodthinners, Savaysa, edoxaban
Lawmaker Plans a Bill to Force Pharma to Disclose Compassionate Use Info
WSJ Pharmalot
Friday, October 31, 2014 - 9:58am
tags:
compassionate use guidelines
Those Old-Boy Networks Can Hinder Women From Climbing Biotech Ranks
WSJ Pharmalot
Friday, October 31, 2014 - 9:57am
tags:
biotech, women
Sanofi Said to Have Contacted AstraZeneca’s Soriot About CEO position
Bloomberg
Friday, October 31, 2014 - 9:55am
tags:
Sanofi, Pharma CEOs, Pascal Soriot
Orphan drugs a niche no longer
Medical Marketing and Media
Friday, October 31, 2014 - 9:40am
tags:
orphan drugs
It's Not Just You: FDA Regulatory Requirements Really Are Increasing
RAPS.org
Friday, October 31, 2014 - 9:35am
tags:
FDA, regulatory
Kimberly-Clark Accused Of Falsely Claiming Its Medical Wear Protects Against Ebola
Bidness Etc.
Friday, October 31, 2014 - 8:30am
tags:
Kimberly-Clark, ebola virus
AbbVie Raises Earnings Guidance After Humira Sales Surge
Bloomberg
Friday, October 31, 2014 - 8:23am
tags:
AbbVie, earnings, Humira
Theravance misses 3Q earnings and revenue expectations
Yahoo/AP
Friday, October 31, 2014 - 8:18am
tags:
Theravance, earnings
Ziopharm posts 3Q loss
Yahoo/AP
Friday, October 31, 2014 - 8:13am
tags:
earnings, Ziopharm
Feeling Dissed, Amgen Sues After Sandoz Abandons the BPCIA Patent Dance Procedures for NEUPOGEN Biosimilar; Alleges Unfair Competition, Patent Infringement, and Theft
FDA Law Blog
Thursday, October 30, 2014 - 5:43pm
tags:
Amgen, Sandoz, Neupogen, biosimilars
Microsoft Unveils Fitness Gadget, Health Tracking
Drug Discovery and Development
Thursday, October 30, 2014 - 5:36pm
tags:
Microsoft, devices, mHealth
3 Pharma Companies Fighting Obesity
Yahoo/Benzinga
Thursday, October 30, 2014 - 5:33pm
tags:
obesity, Orexigen, Arena, Vivus

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.